ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
Ontology highlight
ABSTRACT: The primary objective of this study is to compare the effect of panitumumab versus cetuximab on overall survival (OS) for chemorefractory metastatic colorectal cancer (mCRC) among patients with wild-type Kirsten rat Sarcoma-2 virus (KRAS) tumors.
DISEASE(S): Malignant Neoplasm Of Rectum,Metastatic Colorectal Cancer,Colon Cancer,Previously Treated, Wild-type Kras, Metastatic Colorectal Cancer,Colorectal Cancer,Colorectal Neoplasms
PROVIDER: 2079859 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA